{"database": "lobbying", "table": "lobbying_activities", "rows": [[2427758, "5accf944-29c1-4787-bebe-39b1c3365597", "1T", "THE CONAFAY GROUP, LLC", 401004840, "XERIS PHARMACEUTICALS, INC.", 2020, "first_quarter", "MED", "Biomedical research issues", "HOUSE OF REPRESENTATIVES", 10000, null, 0, 1, "2020-04-16T11:10:47.700000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2427758"], "units": {}, "query_ms": 0.6357979727908969, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}